Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Revenue (2020 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Revenue for 6 consecutive years, with $10.9 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 55.37% to $10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $218.7 million through Dec 2025, up 3024.43% year-over-year, with the annual reading at $218.7 million for FY2025, 3024.43% up from the prior year.
  • Revenue hit $10.9 million in Q4 2025 for IDEAYA Biosciences, down from $207.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $207.8 million in Q3 2025 to a low of $3.0 million in Q4 2021.
  • Historically, Revenue has averaged $21.9 million across 5 years, with a median of $7.9 million in 2023.
  • Biggest five-year swings in Revenue: surged 230.87% in 2022 and later plummeted 72.94% in 2023.
  • Year by year, Revenue stood at $3.0 million in 2021, then surged by 35.79% to $4.0 million in 2022, then fell by 2.49% to $3.9 million in 2023, then skyrocketed by 78.48% to $7.0 million in 2024, then surged by 55.37% to $10.9 million in 2025.
  • Business Quant data shows Revenue for IDYA at $10.9 million in Q4 2025, $207.8 million in Q3 2025, and $7.0 million in Q4 2024.